Procalcitonin is a Predictor for High-Grade Vesicoureteral Reflux in Children: Meta-Analysis of Individual Patient Data

dc.contributor.authorLeroy, Sandrine
dc.contributor.authorRomanello, Carla
dc.contributor.authorGaletto-Lacour, Annick
dc.contributor.authorBouissou, Francois
dc.contributor.authorFernandez-Lopez, Anna
dc.contributor.authorSmolkin, Vladislav
dc.contributor.authorChalumeau, Martin
dc.date.accessioned2026-08-12T17:46:21Z
dc.date.issued2011
dc.departmentFırat Üniversitesi
dc.description.abstractObjective To assess the predictive value of procalcitonin, a serum inflammatory marker, in the identification of children with first urinary tract infection (UTI) who might have high-grade (>= 3) vesicoureteral reflux (VUR). Study design We conducted a meta-analysis of individual data, inCIuding all series of children aged 1 month to 4 years with a first UTI, a procalcitonin (PCT) level measurement, cystograms, and an early dimercaptosuccinic acid scan. Results Of the 152 relevant identified artiCIes, 12 studies representing 526 patients (10% with VUR >= 3) were inCIuded. PCT level was associated with VUR as a continuous (P = .001), and as a binary variable, with a 0.5 ng/mL preferred threshold (adjusted OR, 2.5; 95% CI, 1.1 to 5.4). The sensitivity of PCT >= 0.5 ng/mL was 83% (95% CI, 71 to 91) with 43% specificity rate (95% CI, 38 to 47). In the subgroup of children with a positive results on dimercaptosuccinic acid scan, PCT >= 0.5 ng/mL was also associated with high-grade VUR (adjusted OR, 4.8; 95% CI, 1.3 to 17.6). ConCIusions We confirmed that PCT is a sensitive and validated predictor strongly associated with VUR >= 3 regardless of the presence of early renal parenchymal involvement in children with a first UTI. (J Pediatr 2011;159:644-51).
dc.description.sponsorshipAssistance Publique-Hopitaux de Paris (PHRC) [AOM 05 110]; Fondation pour la Recherche Medicale; French Society of Nephrology
dc.description.sponsorshipSupported by the Assistance Publique-Hopitaux de Paris (PHRC AOM 05 110), the Fondation pour la Recherche Medicale, and the French Society of Nephrology. M.C. has received unrestricted educational grants for other studies, for a total amount lower than (sic)30 000, from Brahms AG, the manufacturer of procalcitonin, 2005 and 2007. The other authors declare no conflicts of interest.
dc.identifier.doi10.1016/j.jpeds.2011.03.008
dc.identifier.endpage651
dc.identifier.issn0022-3476
dc.identifier.issn1097-6833
dc.identifier.issue4
dc.identifier.orcid0000-0001-8175-3706
dc.identifier.orcid0000-0002-6342-4877
dc.identifier.orcid0000-0002-7088-2614
dc.identifier.pmid21511275
dc.identifier.scopus2-s2.0-80052803883
dc.identifier.scopusqualityQ1
dc.identifier.startpage644
dc.identifier.urihttps://doi.org/10.1016/j.jpeds.2011.03.008
dc.identifier.urihttps://hdl.handle.net/11508/61049
dc.identifier.volume159
dc.identifier.wosWOS:000295442000029
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherMosby-Elsevier
dc.relation.ispartofJournal of Pediatrics
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectUrinary-Tract-Infection
dc.subjectC-Reactive Protein
dc.subjectAntibiotic-Prophylaxis
dc.subjectAcute Pyelonephritis
dc.subjectSerum Procalcitonin
dc.subjectFebrile Infants
dc.subjectManagement
dc.subjectChildhood
dc.subjectMulticenter
dc.subjectValidation
dc.titleProcalcitonin is a Predictor for High-Grade Vesicoureteral Reflux in Children: Meta-Analysis of Individual Patient Data
dc.typeArticle

Dosyalar